Accelerate, Coordinate, Evaluate (ACE) Programme
Sign up to ACE news
Hear about ACE outputs when they become available.
About the ACE Programme
The ACE Programme, which was initiated in June 2014, is a unique initiative supported by Cancer Research UK and Macmillan Cancer Support. ACE will run across England for approximately 3 years and was established as an early diagnosis programme that supports the NHS outcome of ‘preventing people from dying prematurely’.
The first wave of the programme incorporates 60 projects which are currently exploring innovative concepts such as referral pathways from primary care professionals other than GPs, primary care engagement to overcome barriers to cancer screening and how best to streamline lung cancer diagnostic pathways, amongst others.
The second wave of the programme this year plans to run six pilots in England trialling a new one-stop diagnostic pathway for patients with non-specific but concerning symptoms; an approach incorporating a Multidisciplinary Diagnostic Centre (MDC). As recommended in the Independent Cancer Taskforce report, published last year, the pilots aim to test the effectiveness of the referral route in the NHS in England.
Through waves 1 and 2 ACE will develop the knowledge base on early diagnosis, evaluating and spreading good practice, to inform cancer commissioning.
The ACE Programme has released its first interim reports:
Read our blogs related to ACE
Partners and funding
ACE is a NHS England initiative with support from Cancer Research UK and Macmillan Cancer Support.
ACE is funded by Cancer Research UK, Macmillan Cancer Support, NHS England and the Department of Health's Policy Research Units. As ACE provides only limited financial support to projects, the majority of project funding has come from local, mostly NHS sources.
Email the team for more information or to hear about ACE outputs when they become available.